[On the significance of secondary fibrinolysis in experimental DIC (author's transl)].
D000818:Animals; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000494:pharmacology; D004211:Disseminated Intravascular Coagulation / Q000097:blood*; D004285:Dogs; D005337:Fibrin / Q000378:metabolism; D005340:Fibrinogen / Q000032:analysis / Q000378:metabolism; D005341:Fibrinolysin / Q000008:administration & dosage / Q000494:pharmacology; D005342:Fibrinolysis / Q000187:drug effects*; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology; D007275:Injections, Intravenous; D008744:Methylamines / Q000008:administration & dosage / Q000494:pharmacology; D013925:Thromboplastin / Q000008:administration & dosage / Q000494:pharmacology
D003509:Cyclohexanecarboxylic Acids; D008744:Methylamines; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D013925:Thromboplastin; D005341:Fibrinolysin